Hanne Gahery

Summary

Country: France

Publications

  1. pmc Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized
    Hanne Gahéry-Ségard
    Département d Immunologie Membre de l IFR 116 INSERM U567, Institut Cochin, 75014 Paris, France
    J Virol 77:11220-31. 2003
  2. ncbi request reprint New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine
    Hanne Gahery
    Institut Cochin, Departement d Immunologie, INSERM U567, CNRS UMR8104, Universite Rene Descartes, 75014 Paris, France
    AIDS Res Hum Retroviruses 22:684-94. 2006
  3. ncbi request reprint HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination
    Hanne Gahery
    INSERM U567, 75014 Paris, France
    AIDS Res Hum Retroviruses 23:427-37. 2007
  4. ncbi request reprint HIV preventive vaccine research at the ANRS: the lipopeptide vaccine approach
    Hanne Gahery
    INSERM U567, Cochin Institute, Immunology Department, CNRS UMR 8104, Paris V University, Paris, France
    Therapie 60:243-8. 2005
  5. doi request reprint Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans
    Suzanne Figueiredo
    Inserm U1016, Institut Cochin, Paris, France CNRS UMR8104, Paris, France Univ Paris Descartes, Paris, France
    Vaccine 32:492-501. 2014
  6. pmc Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients
    Andréa Toma
    Institut National de la Santé et de la Recherche Médicale U561, Hopital Cochin Saint Vincent de Paul, Universite Paris V, 75014 Paris, France
    Proc Natl Acad Sci U S A 102:10581-6. 2005
  7. pmc Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study
    Gilles Pialoux
    APHP, Tenon Hospital, Paris, France
    Clin Vaccine Immunol 15:562-8. 2008

Collaborators

Detail Information

Publications7

  1. pmc Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized
    Hanne Gahéry-Ségard
    Département d Immunologie Membre de l IFR 116 INSERM U567, Institut Cochin, 75014 Paris, France
    J Virol 77:11220-31. 2003
    ..05 compared to three injections), which indicates an increase in the breadth of HIV CD8(+)-T-cell epitope recognition after the boost...
  2. ncbi request reprint New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine
    Hanne Gahery
    Institut Cochin, Departement d Immunologie, INSERM U567, CNRS UMR8104, Universite Rene Descartes, 75014 Paris, France
    AIDS Res Hum Retroviruses 22:684-94. 2006
    ..Lipopeptides induce new anti-HIV T cell responses in vaccinated infected patients and could be used as a new immunotherapy strategy. The majority of these responders induced specific new CD4(+) and CD8(+) T cell responses...
  3. ncbi request reprint HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination
    Hanne Gahery
    INSERM U567, 75014 Paris, France
    AIDS Res Hum Retroviruses 23:427-37. 2007
    ..To conclude, these 26 Nef HLA-DR-restricted peptides could be helpful to better evaluate CD4(+) deficiencies in HIV infection and, for new vaccine designs...
  4. ncbi request reprint HIV preventive vaccine research at the ANRS: the lipopeptide vaccine approach
    Hanne Gahery
    INSERM U567, Cochin Institute, Immunology Department, CNRS UMR 8104, Paris V University, Paris, France
    Therapie 60:243-8. 2005
    ..These approaches have within a short time allowed the assessment of a prime-boost strategy combining a viral vector and lipopeptides...
  5. doi request reprint Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans
    Suzanne Figueiredo
    Inserm U1016, Institut Cochin, Paris, France CNRS UMR8104, Paris, France Univ Paris Descartes, Paris, France
    Vaccine 32:492-501. 2014
    ....
  6. pmc Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients
    Andréa Toma
    Institut National de la Santé et de la Recherche Médicale U561, Hopital Cochin Saint Vincent de Paul, Universite Paris V, 75014 Paris, France
    Proc Natl Acad Sci U S A 102:10581-6. 2005
    ..Four yielded a high frequency of recognition in HLA-A1 and -B8 patients. Three peptides located in the proinsulin region 41-51 were shown to bind several HLA molecules and to be recognized in a high percentage of diabetic patients...
  7. pmc Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study
    Gilles Pialoux
    APHP, Tenon Hospital, Paris, France
    Clin Vaccine Immunol 15:562-8. 2008
    ..Despite the lack of a control arm, these findings warrant a randomized study of therapeutic vaccination with HIV lipopeptides followed by long-term HAART interruption in AIDS-free chronically infected patients...